No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ZVRA241220C6000
- 2.60
- -0.10-3.70%
15min DelayClose Dec 20 16:00 ET
2.65High2.60Low
2.60Open2.70Pre Close3 Volume210 Open Interest6.00Strike Price785.00Turnover0.00%IV1.30%PremiumDec 20, 2024Expiry Date2.49Intrinsic Value100Multiplier-1DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.27Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Top Picks for 2025 in Healthcare, Consumer, Tech, Industrials, Energy and More
Zevra Therapeutics to Be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
Zevra Therapeutics Restructures to Focus on Rare Diseases
Express News | Zevra Therapeutics Inc - Christal M.m. Mickle, Chief Development Officer, and Sven Guenther, Ph.d., Chief Scientific Officer, to Depart Co
Express News | Zevra Therapeutics Inc - Zevra Has Discontinued Its in-House Drug Discovery Activities
Express News | Zevra Therapeutics Inc - to Close Laboratory Facilities in Iowa and Virginia